Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program
M Ujiie - Human vaccines & immunotherapeutics, 2022 - Taylor & Francis
Japan's immunization program resumed proactively recommending the use of the human
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program.
M Ujiie - Human Vaccines & Immunotherapeutics, 2022 - europepmc.org
Japan's immunization program resumed proactively recommending the use of the human
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
[HTML][HTML] Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program
M Ujiie - Human Vaccines & Immunotherapeutics, 2022 - ncbi.nlm.nih.gov
Japan's immunization program resumed proactively recommending the use of the human
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
[PDF][PDF] Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program
M Ujiie - 2022 - scienceopen.com
Japan's immunization program resumed proactively recommending the use of the human
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program
M Ujiie - Human vaccines & immunotherapeutics, 2022 - pubmed.ncbi.nlm.nih.gov
Japan's immunization program resumed proactively recommending the use of the human
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …
papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this …